These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35369520)

  • 21. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.
    Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K
    Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant
    Chen X; Liu M; Zhang P; Leung SSY; Xia J
    ACS Infect Dis; 2021 Aug; 7(8):2192-2204. PubMed ID: 34232613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the antibacterial effects of a short cationic peptide and 1% silver bioactive glass against extensively drug-resistant bacteria, Pseudomonas aeruginosa and Acinetobacter baumannii, isolated from burn patients.
    Moosazadeh Moghaddam M; Eftekhary M; Erfanimanesh S; Hashemi A; Fallah Omrani V; Farhadihosseinabadi B; Lasjerdi Z; Mossahebi-Mohammadi M; Pal Singh Chauhan N; Seifalian AM; Gholipourmalekabadi M
    Amino Acids; 2018 Nov; 50(11):1617-1628. PubMed ID: 30145712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states.
    Wang HY; Cheng JW; Yu HY; Lin L; Chih YH; Pan YP
    Acta Biomater; 2015 Oct; 25():150-61. PubMed ID: 26210284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection.
    Jiang S; Deslouches B; Chen C; Di ME; Di YP
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designer broad-spectrum polyimidazolium antibiotics.
    Zhong W; Shi Z; Mahadevegowda SH; Liu B; Zhang K; Koh CH; Ruan L; Chen Y; Zeden MS; Pee CJE; Marimuthu K; De PP; Ng OT; Zhu Y; Chi YR; Hammond PT; Yang L; Gan YH; Pethe K; Greenberg EP; Gründling A; Chan-Park MB
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31376-31385. PubMed ID: 33229526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.
    Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M
    Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.
    Thandar M; Lood R; Winer BY; Deutsch DR; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2016 May; 60(5):2671-9. PubMed ID: 26856847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.
    Woodburn KW; Jaynes JM; Clemens LE
    Front Microbiol; 2019; 10():1688. PubMed ID: 31396193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria.
    Xiang W; Clemenza P; Klousnitzer J; Chen J; Qin W; Tristram-Nagle S; Doi Y; Di YP; Deslouches B
    Front Microbiol; 2022; 13():889791. PubMed ID: 35694289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane disruptive antimicrobial potential of NK-lysin from yellow catfish (Pelteobagrus fulvidraco).
    Zhu R; Wu YS; Liu XX; Lv X; Wu YQ; Song JJ; Wang XG
    Fish Shellfish Immunol; 2020 Feb; 97():571-580. PubMed ID: 31669280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L
    Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection.
    Melvin JA; Lashua LP; Kiedrowski MR; Yang G; Deslouches B; Montelaro RC; Bomberger JM
    mSphere; 2016; 1(3):. PubMed ID: 27303744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSPphg Lysin from the Extremophilic Thermus Bacteriophage TSP4 as a Potential Antimicrobial Agent against Both Gram-Negative and Gram-Positive Pathogenic Bacteria.
    Wang F; Ji X; Li Q; Zhang G; Peng J; Hai J; Zhang Y; Ci B; Li H; Xiong Y; Deng X; Lin L
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32050494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial Activity of a Lytic Enzyme Encoded by
    Yang Y; Le S; Shen W; Chen Q; Huang Y; Lu S; Tan Y; Li M; Hu F; Li Y
    Front Microbiol; 2018; 9():1778. PubMed ID: 30127777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.